D |
2024-12-10 |
|
Scholar Rock Holding Corp |
4 |
S-Sale |
--D |
1600000.0000 |
9250005.0000 |
1 |
0001727196 |
Common Stock |
D |
2024-11-25 |
|
Scholar Rock Holding Corp |
4 |
S-Sale |
--D |
43887.0000 |
11007279.0000 |
2 |
0001727196 |
Common Stock |
D |
2024-11-25 |
|
Scholar Rock Holding Corp |
4 |
S-Sale |
--D |
208272.0000 |
11051166.0000 |
1 |
0001727196 |
Common Stock |
D |
2024-11-25 |
|
Scholar Rock Holding Corp |
4 |
S-Sale |
--D |
149.0000 |
10850005.0000 |
5 |
0001727196 |
Common Stock |
D |
2024-11-25 |
|
Scholar Rock Holding Corp |
4 |
S-Sale |
--D |
30683.0000 |
10850154.0000 |
4 |
0001727196 |
Common Stock |
D |
2024-11-25 |
|
Scholar Rock Holding Corp |
4 |
S-Sale |
--D |
126442.0000 |
10880837.0000 |
3 |
0001727196 |
Common Stock |
D |
2024-08-08 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
260873.0000 |
6317565.0000 |
2 |
0001253689 |
Common Stock |
D |
2024-08-07 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
61488.0000 |
6578438.0000 |
1 |
0001253689 |
Common Stock |
D |
2024-08-06 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
55732.0000 |
6639926.0000 |
2 |
0001253689 |
Common Stock |
D |
2024-08-05 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
164523.0000 |
6695658.0000 |
1 |
0001253689 |
Common Stock |
D |
2024-08-02 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
286200.0000 |
6860181.0000 |
2 |
0001253689 |
Common Stock |
D |
2024-08-01 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
63564.0000 |
7146381.0000 |
1 |
0001253689 |
Common Stock |
D |
2024-07-30 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
756835.0000 |
7209945.0000 |
3 |
0001253689 |
Common Stock |
D |
2024-07-29 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
363949.0000 |
7966780.0000 |
2 |
0001253689 |
Common Stock |
D |
2024-07-26 |
|
GLYCOMIMETICS INC |
4 |
S-Sale |
--D |
258335.0000 |
8330729.0000 |
1 |
0001253689 |
Common Stock |
A |
2023-10-12 |
|
Scholar Rock Holding Corp |
4 |
P-Purchase |
--D |
2189781.0000 |
11249288.0000 |
1 |
0001727196 |
Common Stock |
A |
2023-10-12 |
|
Scholar Rock Holding Corp |
4 |
P-Purchase |
--D |
10150.0000 |
11259438.0000 |
2 |
0001727196 |
Common Stock |
A |
2023-04-28 |
|
Scholar Rock Holding Corp |
4 |
P-Purchase |
--D |
31557.0000 |
9059507.0000 |
1 |
0001727196 |
Common Stock |
A |
2023-02-24 |
|
GLYCOMIMETICS INC |
4 |
P-Purchase |
--D |
100000.0000 |
8589064.0000 |
1 |
0001253689 |
Common Stock |
A |
2023-02-23 |
|
GLYCOMIMETICS INC |
4 |
P-Purchase |
--D |
200000.0000 |
8489064.0000 |
3 |
0001253689 |
Common Stock |
A |
2023-02-22 |
|
GLYCOMIMETICS INC |
4 |
P-Purchase |
--D |
150000.0000 |
8289064.0000 |
2 |
0001253689 |
Common Stock |
A |
2023-02-21 |
|
GLYCOMIMETICS INC |
4 |
P-Purchase |
--D |
50000.0000 |
8139064.0000 |
1 |
0001253689 |
Common Stock |
A |
2023-02-17 |
|
GLYCOMIMETICS INC |
4 |
P-Purchase |
--D |
200000.0000 |
8089064.0000 |
3 |
0001253689 |
Common Stock |
A |
2023-02-16 |
|
GLYCOMIMETICS INC |
4 |
P-Purchase |
--D |
315266.0000 |
7889064.0000 |
2 |
0001253689 |
Common Stock |
A |
2023-02-15 |
|
GLYCOMIMETICS INC |
4 |
P-Purchase |
--D |
1000000.0000 |
7573798.0000 |
1 |
0001253689 |
Common Stock |
A |
2023-02-09 |
|
GLYCOMIMETICS INC |
4 |
P-Purchase |
--D |
11451.0000 |
6573798.0000 |
1 |
0001253689 |
Common Stock |
D |
2023-01-09 |
|
Scholar Rock Holding Corp |
4 |
S-Sale |
--D |
1094.0000 |
9027950.0000 |
1 |
0001727196 |
Common Stock |
A |
2023-01-05 |
|
Scholar Rock Holding Corp |
4 |
P-Purchase |
--D |
48774.0000 |
9029044.0000 |
1 |
0001727196 |
Common Stock |
A |
2022-10-25 |
|
Scholar Rock Holding Corp |
4 |
P-Purchase |
--D |
130265.0000 |
8980270.0000 |
1 |
0001727196 |
Common Stock |
A |
2022-10-04 |
|
Scholar Rock Holding Corp |
4 |
P-Purchase |
--D |
66000.0000 |
8850005.0000 |
2 |
0001727196 |
Common Stock |
A |
2022-10-03 |
|
Scholar Rock Holding Corp |
4 |
P-Purchase |
--D |
33971.0000 |
8784005.0000 |
1 |
0001727196 |
Common Stock |
D |
2021-08-03 |
|
Omega Therapeutics, Inc. |
4 |
C-Conversion |
--D |
5000000.0000 |
0.0000 |
4 |
0001850838 |
Series C Convertible Preferred Stock |
A |
2021-08-03 |
|
Omega Therapeutics, Inc. |
4 |
P-Purchase |
--D |
875000.0000 |
2273530.0000 |
3 |
0001850838 |
Common Stock |
A |
2021-08-03 |
|
Omega Therapeutics, Inc. |
4 |
C-Conversion |
--D |
1323530.0000 |
1398530.0000 |
2 |
0001850838 |
Common Stock |
A |
2021-07-30 |
|
Omega Therapeutics, Inc. |
4 |
P-Purchase |
--D |
75000.0000 |
75000.0000 |
1 |
0001850838 |
Common Stock |
D |
2021-02-01 |
|
Seer, Inc. |
4 |
S-Sale |
--D |
252545.0000 |
5588366.0000 |
1 |
0001726445 |
Class A Common Stock |
A |
2020-12-16 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
10937500.0000 |
32259461.0000 |
1 |
0001062822 |
Common Stock |
D |
2020-12-08 |
|
Seer, Inc. |
4 |
C-Conversion |
--D |
3953381.0000 |
0.0000 |
3 |
0001726445 |
Series B Convertible Preferred Stock |
A |
2020-12-08 |
|
Seer, Inc. |
4 |
C-Conversion |
--D |
5050911.0000 |
5050911.0000 |
1 |
0001726445 |
Class A Common Stock |
D |
2020-12-08 |
|
Seer, Inc. |
4 |
C-Conversion |
--D |
249221.0000 |
0.0000 |
6 |
0001726445 |
Series D-1 Convertible Preferred Stock |
A |
2020-12-08 |
|
Seer, Inc. |
4 |
P-Purchase |
--D |
790000.0000 |
5840911.0000 |
2 |
0001726445 |
Class A Common Stock |
D |
2020-12-08 |
|
Seer, Inc. |
4 |
C-Conversion |
--D |
474478.0000 |
0.0000 |
5 |
0001726445 |
Series D Convertible Preferred Stock |
D |
2020-12-08 |
|
Seer, Inc. |
4 |
C-Conversion |
--D |
373831.0000 |
0.0000 |
4 |
0001726445 |
Series C Convertible Preferred Stock |
D |
2020-11-03 |
|
SQZ Biotechnologies Co |
4 |
C-Conversion |
--D |
240375.0000 |
0.0000 |
4 |
0001604477 |
Series D Convertible Preferred Stock |
D |
2020-11-03 |
|
SQZ Biotechnologies Co |
4 |
C-Conversion |
--D |
843490.0000 |
0.0000 |
3 |
0001604477 |
Series C Convertible Preferred Stock |
A |
2020-11-03 |
|
SQZ Biotechnologies Co |
4 |
P-Purchase |
--D |
465000.0000 |
1606308.0000 |
2 |
0001604477 |
Common Stock |
A |
2020-11-03 |
|
SQZ Biotechnologies Co |
4 |
C-Conversion |
--D |
1141308.0000 |
1141308.0000 |
1 |
0001604477 |
Common Stock |
D |
2020-06-16 |
|
Generation Bio Co. |
4 |
C-Conversion |
--D |
1073076.0000 |
0.0000 |
4 |
0001733294 |
Series C Preferred Stock |
D |
2020-06-16 |
|
Generation Bio Co. |
4 |
C-Conversion |
--D |
2186820.0000 |
0.0000 |
3 |
0001733294 |
Series B Preferred Stock |
A |
2020-06-16 |
|
Generation Bio Co. |
4 |
C-Conversion |
--D |
2014191.0000 |
2014191.0000 |
1 |
0001733294 |
Common Stock |
A |
2020-06-16 |
|
Generation Bio Co. |
4 |
P-Purchase |
--D |
800000.0000 |
2814191.0000 |
2 |
0001733294 |
Common Stock |
A |
2018-06-28 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
57724.0000 |
3516214.0000 |
2 |
0001062822 |
Common Stock |
A |
2018-06-27 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
125114.0000 |
3458490.0000 |
1 |
0001062822 |
Common Stock |
A |
2018-06-25 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
228264.0000 |
3333376.0000 |
2 |
0001062822 |
Common Stock |
A |
2018-06-22 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
25461.0000 |
3105112.0000 |
1 |
0001062822 |
Common Stock |
A |
2018-06-21 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
51600.0000 |
3079651.0000 |
3 |
0001062822 |
Common Stock |
A |
2018-06-20 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
12391.0000 |
3028051.0000 |
2 |
0001062822 |
Common Stock |
A |
2018-06-19 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
8982.0000 |
3015660.0000 |
1 |
0001062822 |
Common Stock |
A |
2018-06-18 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
36584.0000 |
3006678.0000 |
2 |
0001062822 |
Common Stock |
A |
2018-06-14 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
9200.0000 |
2970094.0000 |
1 |
0001062822 |
Common Stock |
A |
2018-06-12 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
107023.0000 |
2960894.0000 |
3 |
0001062822 |
Common Stock |
A |
2018-06-11 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
98626.0000 |
2853871.0000 |
2 |
0001062822 |
Common Stock |
A |
2018-06-08 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
29747.0000 |
2755245.0000 |
1 |
0001062822 |
Common Stock |
A |
2018-06-07 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
57439.0000 |
2725498.0000 |
3 |
0001062822 |
Common Stock |
A |
2018-06-06 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
95079.0000 |
2668059.0000 |
2 |
0001062822 |
Common Stock |
A |
2018-06-05 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
173121.0000 |
2572980.0000 |
1 |
0001062822 |
Common Stock |
A |
2018-06-04 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
121803.0000 |
2399859.0000 |
3 |
0001062822 |
Common Stock |
A |
2018-06-01 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
147339.0000 |
2278056.0000 |
2 |
0001062822 |
Common Stock |
A |
2018-05-31 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
147339.0000 |
2130717.0000 |
1 |
0001062822 |
Common Stock |
A |
2018-05-30 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
147339.0000 |
1983378.0000 |
3 |
0001062822 |
Common Stock |
A |
2018-05-29 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
147339.0000 |
1836039.0000 |
2 |
0001062822 |
Common Stock |
A |
2018-05-25 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
138700.0000 |
1688700.0000 |
1 |
0001062822 |
Common Stock |
A |
2017-11-17 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
50000.0000 |
1550000.0000 |
2 |
0001062822 |
Common Stock |
A |
2017-11-15 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
130727.0000 |
1500000.0000 |
1 |
0001062822 |
Common Stock |
A |
2017-11-14 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
215133.0000 |
1369273.0000 |
3 |
0001062822 |
Common Stock |
A |
2017-11-13 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
215133.0000 |
1154140.0000 |
2 |
0001062822 |
Common Stock |
A |
2017-11-10 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
145680.0000 |
939007.0000 |
1 |
0001062822 |
Common Stock |
- |
- |
|
SQZ Biotechnologies Co |
3 |
- |
--D |
|
|
1 |
0001604477 |
Series C Convertible Preferred Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
35402689.0000 |
4 |
0001062822 |
Common Stock |
- |
- |
|
SQZ Biotechnologies Co |
3 |
- |
--D |
|
|
2 |
0001604477 |
Series D Convertible Preferred Stock |